Andes Biotechnologies Overview
- Founded
- 2008
- Status
- Out of Business
- Employees
- 3
- Latest Deal Type
- Out of Business
Andes Biotechnologies General Information
Description
Developer of novel therapeutics intended to create a new class of drugs for the treatment of cancer. The company's therapeutics use antisense technologies to target the novel long non-coding regulatory RNAs in tumor cells inducing apoptosis, thereby enabling physicians to selectively destroy cancer cells without affecting normal cells.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Parque Tecnológico Zañartu
- Av. Zañartu, Ñuñoa
- Santiago, 1482
- Chile
+56 000000000
Andes Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 20-Dec-2020 | 0000 | Completed | Out of Business | ||
| 6. Later Stage VC | 01-Jun-2018 | 0000 | 0000 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series B) | 15-Apr-2015 | 0000 | 0000 | Completed | Generating Revenue | |
| 4. Later Stage VC | 10-Mar-2014 | 000 | 000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 10-May-2012 | 000 | 000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 19-May-2011 | $4M | $4M | Completed | Generating Revenue | |
| 1. Grant | 11-Jan-2011 | Completed | Startup |
Andes Biotechnologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial